Language selection

Search

Patent 2397139 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2397139
(54) English Title: IRIS FIXATED INTRAOCULAR LENS
(54) French Title: LENTILLE INTRA-OCULAIRE A FIXATION IRIENNE
Status: Expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61F 2/16 (2006.01)
(72) Inventors :
  • LAGUETTE, STEPHEN W. (United States of America)
  • WEINSCHENK, JOSEPH I., III (United States of America)
(73) Owners :
  • JOHNSON & JOHNSON SURGICAL VISION, INC. (United States of America)
(71) Applicants :
  • ADVANCED MEDICAL OPTICS, INC. (United States of America)
(74) Agent: NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L., S.R.L.
(74) Associate agent:
(45) Issued: 2009-10-13
(86) PCT Filing Date: 2001-01-10
(87) Open to Public Inspection: 2001-07-19
Examination requested: 2005-12-23
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2001/000993
(87) International Publication Number: WO2001/050984
(85) National Entry: 2002-07-12

(30) Application Priority Data:
Application No. Country/Territory Date
09/484,126 United States of America 2000-01-12

Abstracts

English Abstract



Iris fixated intraocular
lenses include an optic and at least one
fixation member or haptic. The fixation
member is joined to the optic and has
a distal segment including a through-iris
portion adapted to extend through an
iris hole, and an anchor portion. The
anchor portion has or is adapted to
have an anchor structure positioned
to be disposed proximate to a side of
the iris so as to be effective in fixating
the intraocular lens to the iris. The
anchor structure may be formed prior to
inserting the intraocular lens in the eye
or may be formed after the intraocular
lens is inserted in the eye. Methods for
inserting such intraocular lenses in the
eye are also provided.


French Abstract

Cette invention se rapporte à des lentilles intraoculaires à fixation irienne qui comprennent une partie optique et au moins un élément de fixation ou partie haptique. Cet élément de fixation est joint à la partie optique et possède un segment distal comportant une partie traversant l'iris destinée à s'étendre à travers le trou de l'iris, ainsi qu'une partie d'ancrage. La partie d'ancrage présente ou est adaptée pour présenter une structure d'ancrage disposée de façon à se situer en position proximale par rapport à un côté de l'iris, pour pouvoir servir à fixer la lentille intraoculaire à l'iris. La structure d'ancrage peut être formée avant ou après l'insertion de la lentille intraoculaire dans l'oeil. Des procédés d'insertion de telles lentilles intraoculaires dans l'oeil sont également présentés.

Claims

Note: Claims are shown in the official language in which they were submitted.



27
WHAT IS CLAIMED IS:


1. An intraocular lens
for fixation to an iris of an eye,
the iris
having a side and a hole extending from the iris
side and through the iris, the intraocular lens
comprising:
an optic; and


at least one fixation member
joined to the optic
and comprising a distal segment
including a through-iris portion
adapted to extend through the iris hole
and an anchor portion
adapted to form an anchor structure, the anchor structure
positioned to be disposed proximate to the
iris side so as to be effective in fixating the
intraocular lens to the iris,
wherein the anchor portion is adapted to form the anchor stucture after the
intraocular lens is placed in the eye.

2. The intraocular lens
of claim 1, wherein the anchor portion
is adapted to be disposed in the posterior chamber
or the anterior chamber.


3. The intraocular lens of claim 1, wherein
the at least one fixation member includes a plate
element joined to the optic and adapted to be
disposed in the anterior chamber, the plate element preferably
being deformable.

4. The intraocular lens of claim 1,
comprising a further anchor portion, which anchor


28

structure is formed prior to the intraocular lens being
placed in the eye.


5. The intraocular lens of claim
1, wherein the anchor portion comprises
a hydrophilic material adapted to form the anchor
structure in the eye.


6. The intraocular lens of claim
5, wherein the hydrophilic material comprises an acid-
treated polymer or a base-treated polymer.


7. The intraocular lens of claim
5, wherein the hydrophilic material comprises a
hydrogel-forming polymeric material.


8. The intraocular lens of claim
1, wherein the anchor portion comprises
an elastic memory material adapted to form the anchor
structure in the eye.


9. The intraocular lens
of claim 1, wherein the anchor structure
has a transverse cross-sectional area
that is larger than a transverse cross-sectional area of
the through-iris portion.


10. The intraocular lens of any one of claims 1 to 9,
which includes at least three of the
fixation members.


29

11. The intraocular lens of any one of claims 1
to 10, wherein the optic
has a thickness in a range of about 200 microns to about
500 microns.


12. The intraocular lens of claim
1, wherein:
the hole in the iris extends between
the side and a substantially opposing side
of the iris; and
the distal segment includes
another anchor portion having or adapted to have another
anchor structure positioned to be
disposed proximate to the substantially opposing iris
side.


13. The intraocular lens of claim 12,
which has
the other anchor structure prior to
the intraocular lens being placed in the eye.


14. The intraocular lens of claim 12,
wherein
the other anchor structure is
constructed to be formed after the intraocular lens is
placed in the eye.


15. The intraocular lens of claim
12, wherein at least one of the anchor structure
and the other anchor structure
has a transverse cross-sectional area that is
larger than a transverse cross-sectional area of the
through-iris portion.


16. The intraocular lens of claim
12, wherein:
the anchor structure is


30

adapted to be disposed in the posterior chamber;
and
the other anchor structure is
adapted to be disposed in the anterior chamber.


17. The intraocular lens of claim 16 wherein
the anchor structure is constructed to be formed
after the intraocular lens is placed in the eye and the
other anchor structure is constructed to be
present prior to the intraocular lens being placed in
the eye.


18. The intraocular lens of claim 12,
wherein:
the anchor portion:
is adapted to enlarge in the eye and
form the anchor structure; or
comprises an elastic memory material
adapted to form the anchor structure
in the eye; and


the other anchor portion:
is adapted to enlarge in the eye and
form the other anchor structure;
or
comprises an elastic memory material
adapted to form the other anchor
structure in the eye; or
has a transverse cross-sectional
area that is larger than a transverse
cross-sectional area of the through-iris
portion.


19. The intraocular lens of claim 1 wherein


31

the anchor structure is adapted to be disposed in
a posterior chamber of the eye and bas a
generally elliptical transverse cross-sectional area.


32

20. Use of an intraocular lens for fixation to an
iris of an eye, the iris having a side and a hole
extending between the iris side and a substantially
opposing side of the iris, the intraocular lens
comprising an optic; and at least one fixation member
joined to the optic and comprising a distal segment
including a through-iris portion adapted to extend
through the iris hole and an anchor portion adapted to
form an anchor structure, the anchor structure
positioned to be disposed proximate to the iris side so
as to be effective in fixating the intraocular lens to
the iris, wherein the distal segment includes another
anchor portion having or adapted to have another anchor
structure positioned to be disposed proximate to the
substantially opposing iris side, the other anchor
structure being constructed to be formed after the
intraocular lens is placed in the eye.


21. The use of claim 20, wherein the anchor
structure is a preformed anchor structure and the
preformed anchor structure can be passed through the
hole of the iris.


22. The use of claim 20, wherein the anchor
portion comprises a hydrophilic material and the anchor
portion can be caused to absorb aqueous fluid and form
the anchor structure.


23. The use of claim 20, wherein the anchor
portion comprises an elastic memory material, and energy
can be directed to the anchor portion, whereby the
anchor portion absorbs the energy and the anchor
structure is formed.


33
24. The use of claim 20, wherein the optic is
deformable during at least a portion of inserting the
intraocular lens into the eye.

25. An intraocular lens for fixation to an iris of
an eye, the iris having a side and a hole extending
between the iris side and a substantially opposing side
of the iris, the intraocular lens comprising:

an optic; and

at least one fixation member joined to the
optic and comprising a distal segment including a
through-iris portion adapted to extend through the iris
hole and an anchor portion adapted to form an anchor
structure, the anchor structure positioned to be
disposed proximate to the iris side so as to be
effective in fixating the intraocular lens to the iris,
wherein the distal segment includes another anchor
portion having or adapted to have another anchor
structure positioned to be disposed proximate to the
substantially opposing iris side, the other anchor
structure being constructed to be formed after the
intraocular lens is placed in the eye.

26. An intraocular lens for fixation to an iris of
an eye, the iris having a side and a hole extending
between the iris side and a substantially opposing side
of the iris, the intraocular lens comprising:

an optic; and

at least one fixation member joined to the
optic and comprising a distal segment including a


34
through-iris portion adapted to extend through the iris
hole and an anchor portion adapted to form an anchor
structure, the anchor structure positioned to be
disposed proximate to the iris side so as to be
effective in fixating the intraocular lens to the iris,
the anchor structure being adapted to be disposed in the
posterior chamber and the other anchor structure being
adapted to be disposed in the anterior chamber, wherein
the anchor structure is constructed to be formed after
the intraocular lens is placed in the eye and the other
anchor structure is constructed to be present prior to
the intraocular lens being placed in the eye.

Description

Note: Descriptions are shown in the official language in which they were submitted.



CA 02397139 2008-10-14

WO 01/50984 PCT/USO1/00993
IRIS FIXATED INTRAOCVLAR LENS

Backaround of the Inventioa

This invention relates to intraocular lenses (IOLs)
and in particular to IOLs that reduce or even eliminate
irritation of the ciliary band or angle and the sulcus in
the eye and reduce the incidence of pupillary block, and,
if a natural crystalline lens is present, to reduce the
risk of cataract formation.
IOLs are commonly used to modify vision. For example,
IOLs are used to replace the natural lens of the eye when
warranted by medical conditions. A common practice is to
implant an IOL in a region of the eye known as the capsular
bag or posterior bag or capsule. However, in this
practice, a potential risk exists that cells from the eye
may grow in front of and/or in back of the optical portion
of the IOL. Such cell growth tends to block the optical
portion of the IOL and impair vision.
IOLs may be implanted in regions of the eye other than
in the capsular bag. Anterior chamber IOLs (AIOLs) and
posterior chamber IOLs (PIOLs) are known in the prior art.
These prior art IOLs are designed such that a portion of
the haptics of the IOLs are located against the angle or
ciliary band of the eye for the AIOLs or against the sulcus
of the eye for the PIOLs.
A disadvantage of the prior art AIOLs is the risk that
the fixation members or haptics of the AIOLs may irritate
the ciliary band. A disadvantage of the PIOLs is the risk
that the optic of the PIOLs may irritate the natural
crystalline lens, if such lens is present, and possibly
result in cataract formation.
Referring now to Prior Art Fig. 1, a
posterior/anterior chamber intraocular lens ("PACL") 10


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
2
combines the advantage of an optic 12 positioned in the
anterior chamber 14 of an eye 16 and haptics 18 that
position the lens resting in the sulcus 20. The PACL 10
reduces the opportunity of irritation to the angle or
ciliary band 22 and the natural lens 24. Such PACLs are
disclosed in U.S. Patent Application No. 09/166,328 filed
October 5, 1998, which is commonly assigned with the
present application and is incorporated herein in its
entirety by reference.-
The eye 16 is comprised of a cornea 26 shown to the
left and an iris 28 shown in the middle of the eye. It is
to be understood that the cornea 26 is at the front of the
eye 16. The iris 28 divides the eye 16 into the anterior
chamber 14 at the front of the eye and the posterior
chamber 30 in the back of the eye. The iris 28 also
defines the pupil 32, which is the opening in the middle of
the iris. In front of the iris 28 is the sclera spur 34.
The sclera spur 34 and the iris 28 delimit the ciliary band
22. Behind the iris 28 is the ciliary process 36, from
which extends the ciliary muscle 38. The ciliary muscle 38
supports the natural crystalline lens 24 of the eye 16.
The iris 28 and the ciliary process 36 define the sulcus
20.
The haptics 18 of the PACL 10 are two opposing
elongated fixation members that extend from the optic 12.
The optic 12 defines an optical axis 50 that extends
through the center 52 of the optic. The haptics 18 have a
proximal segment 54 attached to the optic 12, an
intermediate segment 56, and terminates in a distal segment
58. The optic 12 and the proximal segment 54 are located
in the eye anterior chamber 14. The haptic distal segment
58 rests against the sulcus 20. f
The intermediate segment 56 of the haptic 18 extends
through a hole 60 in the periphery of the iris 28. The
intermediate segment 56 is substantially parallel to the


CA 02397139 2008-10-14

WO 01/509Si PCTlUSOI/00993
3
optical axis 50. The holes 60 may be formed by an
iridectomy, or be naturally occurring openings in the iris
28. The holes 60 have an additional benefit of improving
fluid flow between the anterior chamber 14 and the
posterior chamber 30. Other details of the PACL 10 are
disclosed in the above-incorporated U.S. Patent
Application.
Recently developed AIOLe for insertion in eyes which
contain the natural crystalline lens ("phakic" eyes)
include the Nuvitas" N!A-20 lens, which has a four-point
haptic for fixation in the angle, and is made of rigid
polymethyl methacrylate (PlrIIrtA). Another AIOL used in
phakic eyes is knoti+n as the Artisane` lens and is disclosed
in Worst U.S. Patent No. 5,192,319.
i5 This AIOL is fixated
on the iris by "pinching" the iris tissue. Made of rigid
PirIIrtA, the Artisan'" lens is difficult to implant due to the
delicacy of the iris tissue. Worst U.S. Patent No.
4,215,440,
discloses another iris-fixated AIOL, wtiicti uses
one or more fixation members, each having a pair of pincer
arms that pinch an anterior surface of the iris. This AIOL
detachably attaches the IOL to the iris such that the optic
is positioned in the iris opening and has many of the same
disadvantages as does the Artisan!K lens. Suzuki U.S.
Patent No. 5,628,796,
discloses an AIOL with fixation arms
or support legs that are inserted in and through fine bores
or apertures made by incision in a peripheral sits of the
iris.
Disadvantages associated with theee IOLs for phakic
implantation include a requirement for large incisions in
the cornea for non-foldable IOLs and potential for damage
and inflamiaation to delicate tissue from rigid hapties.
Also involved are one or more of the complications which


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
4
include corneal endothelial cell loss due to mechanical
abrasion against the cornea, inflammation, pupil
ovalization, problems with aqueous flow in the iridio-
corneal angle, and implant decentration.
There continues to be a need for new IOLs.
Summary of the Invention

New iris fixated intraocular lenses (IFIOLs) have been
discovered. The present IFIOLs are relatively easy and
straightforward to implant in the eye and effectively
fixate to the iris of the eye. The'present IFIOLs are
adapted to be firmly fixated to the iris, for example, so
as to prevent accidental dislodgement. These IFIOLs can be
sized and structured so as not to interfere with the
zonules and sulcus angle of the eye, and with the natural
lens of the eye, if such natural lens is present.
The iris to which the present IFIOL is fixated has a
side and a hole, for example, a iridectomy hole or opening,
extending from the iris side and through the iris. In one
broad aspect, the present IFIOLs comprise an optic and at
least one fixation member or haptic. The fixation member
is joined to the optic and includes a distal segment
including a through-iris portion adapted to extend through
the iris hole and an anchor portion. The anchor portion
has or is adapted to have an anchor structure positioned to
be disposed proximate to the iris side so as to be
effective in fixating the IFIOL to the iris.
In one aspect of the invention, the optic is adapted
to be disposed in the anterior chamber while the anchor
portion is adapted to be disposed in the posterior chamber
or the anterior chamber, preferably in the posterior
chamber.
The anchor portion may have the anchor structure prior
to the intraocular lens being placed in the eye or the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
anchor portion may be adapted to form the anchor structure
after the intraocular lens is placed in the eye.
In one embodiment, the anchor portion adapted to form
the anchor structure after insertion or placement in the
5 eye may be comprised of hydrophilic material adapted to
absorb aqueous fluid and form the anchor structure in the
eye. The hydrophilic material used may be any suitable
such material, for example, a material suitable for use in
the eye. Examples of useful hydrophilic materials include,
but are not limited to, acid-treated polymers, base-treated
polymers, hydrogel-forming polymeric materials and the like
and mixtures and combinations thereof.
In another embodiment of the invention, the anchor
portion adapted to form the anchor structure after
insertion in the eye may be comprised of an elastic memory
material adapted to form the anchor structure in the eye.
Any suitable elastic memory material may be employed,
provided that such material is useful in the eye and can be
treated in the eye to form the anchor structure at
conditions which do not detrimentally affect the eye.
Examples of useful elastic memory materials are well known
in the art.
In one embodiment, the anchor structure has a
transverse cross-sectional area that is larger than a
transverse cross-sectional area of the through-iris portion
of the fixation member. Also, the through-iris portion
may, and preferably does, have a longitudinal axis oriented
in a direction other than normal to an optical axis of the
optic.
The IFIOLs of the invention may have at least three
fixation members, for example, three or four fixation
members, but may also have any number of such members.
Further, not all of the fixation members need be adapted to
fixate to the iris.


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
6
In one particularly useful embodiment, fixation member
or members include a plate, or plate-like, element joined
to the optic. Such plate elements have been found to
effectively facilitate fixating the present IFIOLs to the
iris. For example, the plate elements are effective in
reducing, or even substantially eliminating, movement of
the optic in the eye which can disadvantageously cause
vision distortion. One important feature of these plate
elements is in facilitating the placement of the IFIOLs in
the eye. Thus, the relatively large and strong plate
elements provide a degree of structural rigidity and are
adapted to facilitate passing the distal segments of the
fixation members into and through the holes in the iris.
Such facilitation increases the ease with which the IOL is
installed in the eye and, thereby advantageously, reduces
patient trauma and/or surgeon stress.
In one aspect of the invention, the distal segment of
the fixation member includes an other or an additional
anchor portion having or adapted to have an other or an
additional anchor structure. In this aspect, the first
anchor portion is adapted to be disposed on one side of the
iris, the second anchor portion preferably is adapted to be
disposed on the other side of the iris, and the through-
iris portion of the distal segment extends through the iris
hole and between the two anchor portions. One or both of
the two anchor structures may be formed prior to insertion
of the IFIOL into the eye or may be formed after the IFIOL
is placed in the eye. One of the anchor structures
preferably is adapted to be disposed in the posterior
chamber while the other anchor structure preferably is
adapted to be disposed in the anterior chamber. In a very
useful embodiment, the anchor structure is adapted to be
formed after the IFIOL is placed in the eye and the other
anchor structure is adapted to be present prior to the
intraocular lens being placed in the eye. The two anchor


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
7
structures may have substantially the same or different
configurations.
In one embodiment, one or both of the anchor portion
and the other anchor portion are adapted to enlarge in the
eye and form an anchor structure, or comprise an elastic
memory material adapted to form an anchor structure in the
eye, or have a transverse cross-sectional area that is
larger than a transverse cross-sectional area of the
through-iris portion of the fixation member.
In one embodiment, the anchor structure adapted to be
disposed in a posterior chamber of the eye has a generally
elliptical transverse cross-sectional area. This is
particularly useful when the anchor structure is formed
prior to the IFIOL being placed in the eye. Such
elliptical cross-sectional area facilitates placing the
preformed anchor structure through the hole in the iris.
Methods of fixating an IOL, for example, the present
IFIOLs, to an iris of an eye have been discovered. Such
methods comprise inserting or placing the IOL into the eye,
for example, through an incision in the eye. A distal
segment of a fixation member of the IOL is directed through
a through-hole extending through the iris such that a
through-iris portion of the distal segment is disposed in
the hole. The hole in the iris may be formed as part of
the present methods, for example, employing conventional
iridectomy techniques. An anchor structure of the distal
segment is disposed or placed proximate to a side of the
iris so that the anchor structure is adjacent the through-
iris portion and the anchor structure is effective in
fixating the intraocular lens to the iris.
In one embodiment, the anchor structure is a preformed
anchor structure and the disposing step includes passing
the preformed anchor structure through the through hole in
the iris. Alternately, the present methods may include a
step of changing the shape of an anchor portion of the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
8
distal segment in the eye to form the anchor structure. In
this embodiment, the anchor portion may comprise a
hydrophilic material and the changing step includes causing
the anchor portion to absorb aqueous fluid, for example,
from the eye, and form the anchor structure. The anchor
portion may comprise an elastic memory material, and the
changing step includes directing energy to the anchor
portion, whereby the anchor portion absorbs the energy and
the anchor structure is formed.
Each and every feature described herein, and each and
every combination of two or more of such features is
included with the scope of the present invention provided
that the features included in such a combination are not
mutually inconsistent.
These and other aspects of the present invention are
apparent in the following detailed description and claims,
particularly when considered in conjunction with the
accompanying drawings in which like parts bear like
reference numerals.

Brief Description of the Drawings

Prior Art Fig. 1 is a cross-sectional view of an eye
with a posterior/anterior intraocular lens implanted
therein.
Fig. 2 is a perspective view of an iris fixated
intraocular lens before implantation in an eye according to
an embodiment of the invention.
Fig. 3 is a cross sectional view of the iris fixated
intraocular lens of Fig. 2 implanted in an eye with formed
anchor structures of hydrogel at the ends of the fixation
members.
Fig. 4 is a detail view of the formed anchor structure
of the iris fixated intraocular lens fixation member of
Fig. 3.


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
9
Figs. 5 and 6 are detail views of formed anchor
structures of the iris fixated intraocular lens made of
elastic memory material.
Fig. 7 is a perspective view of an iris fixated
intraocular lens before implantation in an eye according to
an embodiment of the invention.
Fig. 8 is a cross sectional view of the iris fixated
intraocular lens of Fig. 7 implanted in an eye with formed
anchor structures at the ends and intermediate portions of
the fixation members.
Fig. 9 is a perspective view of an iris fixated
intraocular lens before implantation in an eye according to
an embodiment of the invention.
Fig. 10 is a cross sectional view of the iris fixated
intraocular lens of Fig. 9 implanted in an eye with formed
anchor structures at the ends and preformed anchor
structures at the intermediate portions of the fixation
members.
Fig. 11 is a perspective view of an iris fixated
intraocular lens before implantation in an eye according to
an embodiment of the invention.
Fig. 12 is a side view of the iris fixated intraocular
lens of Fig. 11 showing the vaulting of the optic relative
to the fixation members.
Fig. 13 is a cross sectional view of the iris fixated
intraocular lens of Fig. 11 implanted in an eye with
preformed anchor structures at the ends at the intermediate
portions of the fixation members.
Figs. 14 and 15 are detail views of anchor portions of
fixation members of the iris fixated intraocular lens of
Fig. 11 according to embodiments of the invention.
Fig. 16 is a front view of an alternate iris fixated
intraocular lens before implantation in an eye according to
an embodiment of the present invention.
Fig. 17 is a side view of the iris fixated intraocular


CA 02397139 2007-12-21
WO 01/5()984 PC'F/US01/00993
lens of Fig. 16.

Detailed Desarifltion ol the Drawiace
Referring now to drawings, Fig. 2 shows an iris
fixated intraocular lens ("IFIOL") 110 according to an
5 embodiment of the invention in which the fixation members
118 come into contact with neither the sulcus nor the angle
or ciliary band of the eye. The IFIOL 110 is comprised of
an optic 112 and three fixation members or haptics 118.
The optic 112 has an optical axis 150 extending through the
10 center 152 of the optic and is generally normal to the
optic. Each fixation member 118 has an elongated proximal
segment 154 attached to the optic 112 near the periphery
113 of the optic. Each fixation member also has a distal
segment 156 joined to the proximal segment 154, comprising
a through-iris portion 157 and preferably terminating in a
shape -changeable end 158.
The optic 112 in the shown embodiment is circular in
plan and bi-convex (see Fig. 3). Other embodiments of the
invention may have other configurations and shapes, such as
convex-concave, bi-concave, planar-convex, planar concave,
toric, and multifocal, for example, as disclosed in Portney
U.S. Patent No. 5,225,858.

The optic 112 may be constructed of any commonly
employed material or materials used for rigid optics, such
as polymethylmethacrylate (PPMA), or commonly used for
resiliently deformable or foldable optics, such as silicone
polymeric materials, acrylic polymeric materia2s, hydrogel-
forming polymeric materials, such as
polyhydroxyethylmethacrylate, polyphosphazenes,
polyurethanes, and mixtures thereof and the like. The
particular material should form an optically clear optic
112 and exhibit biocompatability in the environment of the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
11
eye 16. Selection parameters for suitable intraocular lens
materials are well known to those of skill in the art.
See, for example, David J. Apple, et al., Intraocular
Lenses. Evolution, Design, Complications, and Pathology,
(1989) William & Wilkins. Foldable/deformable materials
are particularly advantageous since optics made from such
deformable materials may be rolled, folded or otherwise
deformed and inserted into the eye through a small
incision. It is preferred that the lens material has a
refractive index allowing a relatively thin, and preferably
flexible optic section, for example, having a thickness in
the range of about 150 microns to about 1000 microns, and
preferably about 150 microns or about 200 microns to about
500 microns. Further, the optic 112 may have a diameter of
about 4.5 mm or less to about 6.6 mm or more, preferably
about 5.0 mm to about 6.0 mm or about 6.5 mm, to avoid edge
glare and be properly sized for placement in an adult human
eye. In comparison, the distal segments 156 lie on a
circle having a diameter of about 8 mm or less to about 11
mm or more, for example, about 9.5 mm, in an embodiment of
the invention.
The fixation members 118 preferably are flexible yet
sufficiently strong and resilient to hold the optic 112 in
place yet permit the fixation members to flex in response
to iris 28 movement. The fixation member may have a
substantially circular transverse area diameter in a range
of about 0.1 mm or less and about 0.2 mm or more, for
example about 0.15 mm. Other embodiments of the invention
may have fixation members with transverse areas of other
shapes, such as oval, rectangular and the like. The
fixation members 118 preferably are designed to flex so as
to restrict or substantially eliminate movement of the
optic 112 in the direction of the optical axis 150.
Optics and haptics in accordance with the present
invention having the above-noted thicknesses and diameters


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
12
can be produced using manufacturing methodologies which are
conventional and well known in the IOL art.
The fixation members 118 may be formed integrally with
the optic 102 or may be separately attached to the optic.
The fixation members 118 may comprise any of a variety of
materials which exhibit sufficient supporting strength and
resilience, and which are substantially biologically inert
in the intended in vivo or in-the-eye environment.
Suitable materials for this purpose include, for example,
polymeric materials such as polypropylene, PMMA,
polycarbonates, polyamides, polyimides, polyacrylates, 2-
hydroxymethylmethacrylate, poly (vinylidene fluoride),
polytetrafluoreothylene and the like; and metals such as
stainless steel, platinum, titanium, tantalum, shape-memory
alloys, e.g., nitonal, and the like.
More preferably, the fixation members 118 comprise a
polymeric material, in particular selected from
polypropylene, PMMA and polyimides, and especially
polypropylene. The fixation members 118 can be produced
using conventional and well known forming techniques. For
example, the preferred polymeric fixation members can be
formed in accordance with known thermoplastic polymer
forming techniques, such as by injection molding or by
extrusion. Further, selection parameters for suitable
intraocular lens materials are well known to those skilled
in the art.
Each fixation member proximal segment 154 defines an
arc that extends generally normal to the optical axis 150.
Each fixation member 118 has a discontinuity 160 where the
proximal segment 154 joins the distal segment 156. In the
shown embodiment of the invention, the proximal and distal
segments 154 and 156 form a right angle 162, resulting in
the iris-through portion 157 being parallel to the optical
axis 150. Other embodiments of the invention may have the
through-iris portion 157 oriented in a direction other than


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
13
normal to the optical axis 150. Still other embodiments of
the invention may have proximal segments 154 of any
suitable configuration.
In the shown embodiment, the three fixation members
118 are symmetrical. Other embodiments of the invention
may have non-symmetrical fixation members. In the shown
embodiment of the invention, the fixation members 118
extend generally tangentially away from the optic periphery
113. Other embodiments of the invention may have fixation
members 118 attached to the optic 112 which extend in a
non-tangential fashion. Still other embodiments of the
invention may have any number of fixation members of
similar or different design. The shown embodiment of the
invention has three fixation members 118 to increase
stability of the IFIOL in the eye. Embodiments of the
invention may have optics and fixation members that are
essential unitary or may be assembled.
In an embodiment of the invention, the fixation
members 118 are made of two or more materials. In a
further embodiment of the invention, the shape-changeable
end 158 may be comprised of a different material than the
remainder of the fixation member 118.
Referring now to Figs. 3 and 4 as well, the shape-
changeable end 158 of the fixation member 118 is adapted to
form an anchor structure 158a once the IFIOL 110 is
implanted in the eye 16. The cross-sectional view shown in
Fig. 3 is such that two of the three fixation members 118
are represented for clarity, although a straight cross-
section would only show one of the three fixation members.
Prior to implantation, an iridectomy is performed to
form the holes 60 that extend through the iris 28. The
iridectomy is surgically formed using methods and
instruments, well known in the art. See, for example, the
Apple et al, publication noted previously. The hole 60 is
formed through the iris 28 so that the hole 60 receives the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
14
fixation member 118 and the fixation member fixably engages
the IFIOL 110 to the iris. Fixed to the iris 28, the optic
112 of the IFIOL 110 is aligned with the pupil 32. In some
embodiments of the invention, the fixation member 118
deforms the hole 60 while being inserted and in other
embodiments the fixation member does not deform the hole,
as described below.
The iridectomy facilitates fluid flow between the
anterior chamber 14 and the posterior chamber 30. In a
preferred embodiment of the invention, the holes 60 are
near the outer periphery of the iris 28 because the radial
positions of the holes do not substantially change during
dilation and contraction of the iris compared to portions
of the iris nearer the pupil. Other embodiments of the
invention may have the holes 60 located other than the
outer periphery of the iris 28. The holes 60 extend
generally parallel to the optical axis 150. Other
embodiments of the invention may have the holes 60
extending other than parallel to the optical axis 150. The
holes 60 may be of any shape, including circular, oval, or
slit.
In the shown embodiment of the invention, the IFIOL
110 is implanted such that the optic 112 and the proximal
segments 154 of the fixation members 118 are disposed in
the anterior chamber 14. With the optic 112 in the
anterior chamber 14, there is a reduced opportunity for the
IFIOL 110 to contact the natural lens 24 and initiate
pupillary block and cataract formation. However, it should
be understood that IFIOL 110 can be implanted in and
function satisfactorily in an eye in which the natural lens
has been extracted, e.g., using conventional techniques, or
in an eye in which the natural lens has been extracted and
replaced by an intraocular lens, e.g., of conventional
design, located in the posterior chamber. Additionally,
embodiments of the invention include IFIOLs adapted for the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
optic to be in the posterior chamber 30.
Further, the IFIOL 110 is implanted such that the
fixation member distal segments 156 extend through the iris
hole 60. More specifically, the through-iris portion 157
5 is disposed in the iris hole 60 and the formed anchor
structure 158a is disposed in the posterior chamber 30 and
proximate to an iris side 28a that defines the posterior
chamber.
The formed anchor structure 158a has a diameter 170
10 that is greater than a diameter 172 of the hole 60. When
the distal segment 156 was originally inserted through the
hole 60, the shape-changeable end 158 (see Fig. 2) is able
to pass through the hole without substantially deforming
the walls 61 of the hole and potentially enlarging or
15 tearing the hole.
In the shown embodiment of the invention, the shape-
changeable end 158 comprises a hydrophilic material that
absorbs aqueous fluid in the eye 16 and swells to form the
bulbous anchor structure 158a after passing through the
hole 60. The formed anchor structure 158a cannot pass back
through the hole 60 due to its diameter 170 relative to the
diameter 172 of the hole without deforming the iris hole
walls 61. Further, as the anchor structure diameter 170 is
greater than the hole diameter 172, the cross-sectional
area of the anchor structure 158a is greater than the
cross-sectional area of the hole 60. The cross-sectional
area of the hole 60 is taken normal to the axis 173 of the
hole. The cross-sectional area of the anchor structure
158a is taken normal to the centerline 175 of the fixation
member at the anchor structure.
Embodiments of the invention include any suitable
arrangement of any hydrophilic material that results in the
formed anchor structure 158a that cannot pass through the
hole 60 without deforming the walls 61 of the hole. The
shown embodiment of the invention has a bulbous shape, but


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
16
embodiments of the invention are not limited to hydrophilic
material that forms a bulbous shape upon absorption of
fluid. For example, the formed anchor structure of other
embodiments may be any rotational shape, partial rotational
shape, or non-rotational shape that has a width greater
than a width of the hole 60, whereby the anchor structure
cannot be directed through the hole without distorting the
hole.
It is understood that "width" is a length of the span
of the opening of the hole 60 or the anchor portion in a
direction normal to the axis of the hole. In the case of
a circular anchor structure and a circular opening of the
hole 60, the width is a diameter. In the cases of non-
circular holes and anchor structures, the width is any
span. Additionally, when the IFIOL 110 is installed in the
eye 16, the widths of respective anchor structures and
holes are oriented such that the anchor structure cannot be
directed through the hole without distorting the hole.
Examples of hydrophilic materials of the shape-
changeable-end 158a of embodiments of the invention include
acid or base treated polymeric materials. The shape-
changeable end 158a may comprise a hydrogel-forming
polymeric material, either entirely or a portion, such as
a coating on a non-hydrogel-forming component of the shape-
changeable end. Examples of suitable hydrogel-forming
polymeric materials include poly(2-hydroxyethyl
methacrylate) and a copolymer of ethyl methacrylate and
N,N-dimethylacrylamide.
The shape-changeable end 158a may be the result of
treating the end of the fixation member 118 with acid or
base, which reacts with the fixation member material, such
as PMMA or other suitable material effective when treated
with an acid and/or base to provide a useful hydrophilic
material, to form a hydrophilic outer layer. In further
embodiments of the invention, the hydrophilic material is


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
17
coated with a dissolvable or otherwise removable or
breachable biocompatible sealer to temporarily inhibit the
material absorbing the fluid, thereby providing a period of
time before the material swells to form the anchor
structure.
Referring now to Fig. 5 as well, in another embodiment
of the invention, the shape-changeable end 158 of the
fixation member 118 is comprised of an elastic memory
material that changes from a linear state to a curled state
to form the anchor structure 158b. Attention is drawn to
the curled formed anchor 158b structure having an end 159b
that is not in contact with the iris side 28a, which
reduces irritation to the iris 28. The formed anchor
structure 158b is also curled in a direction parallel to
the through-iris portion 157.
Referring now to Fig. 6, an anchor structure 158c is
formed of elastic memory material that forms a curl that is
normal to the direction of the through-iris portion (not
shown). Other embodiments of the invention may include
shape-changeable ends of elastic memory material that form
any suitable formed anchor structure i.e., an anchor
structure that cannot be directed through the iris hole 60
without deforming the iris hole walls 61 or an anchor
structure having a width greater than a width of the iris
hole. In a preferred embodiment of the invention, the
formed anchor structures 158b and 158c are the result of
pinpoint heating of the shape-changeable end 158 by use of
an appropriate energy source, such as a laser. The shape-
changeable end 158 absorbs the energy and forms the anchor
structure.
In an embodiment of the invention, the elastic memory
material is a polymeric material having a glass transition
temperature (Tg) of at least about 40 C to about 45 C,
preferably in the range of about 40 C to about 80 C, and
more preferably in the range of about 45 C to about 60 C.


CA 02397139 2007-12-21
WO 01/50984 PCT/US01/OQ193
18
The polymeric material should be such that the Tg is
sufficiently high to avoid any changes in the material
caused by the physiological environment of the eye. On the
other hand, the Tg of the polymeric material should not be
excessively high, since heating the material to excessively
high temperatures may result in damage or injury to the
eye. Suitable polymeric materials are disclosed in the
Weinschenk, III et al U.S. Patent No. 5,567,365.

The elastic memory polymeric material, as well as the
material from which the optic is derived, used should be
compatible with the eye 16 so implantation of the IFIOL 110
does not cause any significant harm or damage to the eye.
Further, the optic 112 and the fixation members 118 may
also comprise the polymeric material.
Typical examples of useful elastic memory polymeric
materials include homopolymers of and copolymers derived
from methyl methacrylate, n-hexyl acrylate, ethyl
methacrylate, ethyl acrylate, 3,3-dimethylbutyl
methacrylate, isobutyl methacrylate, cyclohexyl
methacrylate, sec-butyl methacrylate, benzyl methacrylate,
4-tert-butylphenyl acrylate, 4-ethoxycarbonyl phenyl
acrylate, 2-methoxycarbonyl phenyl acrylate, 3-
methoxycarbonyl phenyl acrylate, 4-methoxycarbonyl phenyl
acrylate, phenyl acrylate, and the like and mixtures
thereof. Elastic memory polymeric materials other than
acrylic-based materials, such as certain acrylamides,
polyolefins, polycarbonates and the like may be used in
embodiments of the invention. Copolymers are particularly
useful as they may be custom formulated to obtain specific
Tg and other properties desired.
Figs. 7 and 8 show alternative IFIOL 210 of the
present invention. Alternative IFIOL 210 is structurally
and functionally similar to IFIOL 110 except as expressly
described herein. Components of alternative IFIOL 210


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
19
which correspond to components of IFIOL 110 are identified
by the same reference number increased by 100.
Referring now to Fig. 7, IFIOL 210 is comprised of an
optic 212 and three fixation members or fixation members
218. The optic 212 has an optical axis 250 extending
through the center 252 of the optic and is generally normal
to the optic. Each fixation member 218 has a proximal
segment 254 attached to the optic 212 near the periphery
213 of the optic. Each fixation member also has a distal
segment 256 joined to the proximal segment 254, comprising
a through-iris portion 257, terminating in a shape-
changeable end 258, and having a shape-changeable portion
259 between the through-iris portion and the proximal
segment.
The IFIOL 210 is similar to the IFIOL 110 described
above but for the shape-changeable portion 259. The shape-
changeable portion 259 is adapted to form an additional
anchor structure 259a once the IFIOL 210 is implanted in
the eye 16 as shown in Fig. 8.
The formed additional anchor structure 259a is adapted
to be disposed in the proximity of the iris side 28b, which
defines the anterior chamber 14 and opposes iris side 28a.
The anchor structure 258a and the additional anchor
structure 259a straddle the iris 28 to hold the through-
iris portion 257 in the iris hole 60. Other embodiments of
the invention may include any shape-changeable end 258 and
shape-changeable portion 259 of elastic memory material or
hydrogel-forming polymeric material that forms any suitable
formed anchor structure i.e., an anchor structure that
cannot be directed through the iris hole 60 without
deforming the iris hole walls 61 or an anchor structure
having a width greater than a width of the iris hole.
In embodiments of the invention, the shape-changeable
end 258 and the shape-changeable portion 259 may comprise
any of the materials discussed above in connection with the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
shape-changeable end 158 of IFIOL 110. It also follows
that the anchor structure 258a and the additional anchor
structure 259a may be formed in the same manner as
discussed above in connection with the shape-changeable end
5 158. In the embodiment of the invention in which the
shape-changeable portion 259 is comprised of an elastic
memory material, the formed additional anchor structure
259a is suitable as an intermediately positioned component
of the fixation member 218, as opposed to the terminally
10 positioned anchor structure 258a.
Figs. 9 and 10 show additional IFIOL 310 of the
present invention. Additional IFIOL 310 is structurally
and functionally similar to IFIOL 110 and IFIOL 210 except
as expressly described herein. Components of additional
15 IFIOL 310 which correspond to components of IFIOL 110 and
IFIOL 210 are identified by the same reference number
increased by 200 and 100, respectively.
Referring now to Fig. 9, IFIOL 310 is comprised of an
optic 312 and three fixation members 318. The optic 312
20 has an optical axis 350 extending through the center 352 of
the optic and is generally normal to the optic. Each
fixation member 318 has a proximal segment 354 attached to
the optic 312 near the periphery 313 of the optic. Each
fixation member also has a distal segment 356 joined to the
proximal segment 354, comprising a through-iris portion
357, terminating in a shape-changeable end 358, and having
a preformed anchor structure 359 between the through-iris
portion and the proximal segment.
Referring now to Fig. 10, the IFIOL 310 is similar to
the IFIOL 210 described above but for the preformed anchor
structure 359 replacing the shape-changeable portion 259.
The preformed anchor structure 359 does not pass through
the hole 60 in the iris 28 and, therefore, has a width
greater than a width of the iris hole or otherwise cannot
pass through the iris hole without deforming the iris hole


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
21
wall 61. The resulting implanted IFIOL 310 is similar to
the implanted IFIOL 210.
Figs. 11 - 15 show further IFIOL 410 of the present
invention. Further IFIOL 410 is structurally and
functionally similar to IFIOLs 110, 210 and 310 except as
expressly described herein. Components of further IFIOL
410 which correspond to components of IFIOLs 110, 210, and
310 are identified by the same reference number increased
by 300, 200, and 100, respectively.
Referring now to Fig. 11, in an embodiment of the
invention, IFIOL 410 is comprised of an optic 412 and three
fixation members 418. The optic 412 has an optical axis
450 extending through the center 452 of the optic and is
generally normal to the optic. Each fixation member 418
has a proximal segment 454 attached to the optic 412 near
the periphery 413 of the optic. Each fixation member 418
also has a distal segment 456 joined to the proximal
segment 454, comprising a through-iris portion 457,
terminating in a preformed anchor structure 358, and having
another preformed anchor structure 459 between the through-
iris portion and the proximal segment.
Referring now to Figs. 12 and 13, the IFIOL 410 is
shown with an optical plane 480 that is normal to the
optical axis 450. The fixation members 418 extend
posteriorly from the optical plane 480, such that the lens
412 is vaulted. The posteriorly positioning of the
fixation members 418 result in the fixation members and the
optic 412 being supported in a spaced apart position to the
iris 28. This provides the advantage of mitigating
inflammation of the iris 28 by reducing or eliminating
abrasion of the fixation members 418 against the iris
surface 28b.
Referring now to Figs. 14 and 15, embodiments of the
invention have a distal segment 456 with a circular
preformed anchor structure 458a and an ellipsoidal


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
22
preformed anchor structure 458b. The ellipsoidal preformed
anchor structure 458b is relatively easy to pass through
the iris hole and, once through the hole, remains posterior
to the iris. In one embodiment, the through iris portion
457b, or at least that part of the through iris portion
which is directly adjacent to ellipsoidal preformed anchor
structure 458b, may be made of an elastic memory material,
as described elsewhere herein. The through iris portion
4'57b is produced and structured so that the ellipsoidal
anchor structure 458b can be passed through a hole in the
iris and, afterward, because of the elastic memory
characteristic of the through iris portion, is effectively
twisted to rotate the anchor structure 458b, for example,
through an angle of about 900, to make it more difficult
for the anchor structure to pass through the iris hole.
Thus, the anchor structure 458b is more securely positioned
posterior of the iris and the IOL is more securely fixated
to the iris. This is but one example of embodiments of the
present invention in which combinations of preformed anchor
structures and elastic memory materials can advantageously
be used together. Other embodiments of the invention may
have preformed anchor structures 458 and 459 of any
suitable shape, including shapes that minimize contact with
the iris 28 and shapes that permit fluid exchange between
the two chambers through the iris through-hole (see Fig.
13).
Figs. 16 and 17 show alternate IFIOL 510 in accordance
with the present invention. Alternate IFIOL 510 is
structurally and functionally similar to the IFIOLs 110,
210, 310 and 410 except as expressly described herein.
Components of alternate IFIOL 510 which correspond to
components of IFIOLs 110, 210, 310 and 410 are identified
by the same reference number increased by 400, 300, 200 and
100, respectively.
The primary difference between IFIOL 510 and the


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
23
earlier illustrated IFIOLs relates to the structure of the
fixation members 518.
Thus, referring now to Figs. 16 and 17, alternate
IFIOL 510 is comprised of an optic 512 and three fixation
members 518 equidistantly spaced apart around the circular
periphery 513 of the optic. The optic 512 has an optical
axis 550 extending through the center 552 of the optic and
is generally normal to the plane of the optic.
Each fixation member has a plate or tab element 80
attached to the optic 512 near the periphery 513 of the
optic. The plate elements 80 are adapted to be placed or
disposed in the anterior chamber of the eye when the IFIOL
510 is fixated to the iris of the eye. In addition, each
fixation member 518 has a distal segment 556 joined to
plate element 80 near the distal end 824 of the plate
element. Each distal segment 556 includes a through-iris
portion 557, terminating in a preformed anchor structure
559. The plate elements 80 are shaped so that the distal
end 82 is slightly posterior of the regions of the plate
elements 80 directly attached to the optic 512. This
shaping of the plate elements 80 allows the distal end 82
to act as or be considered another preformed anchor
structure which facilitates maintaining the through-iris
portion 557 of each of the fixation members 518 in the iris
hole. It is to be understood that the preformed anchor
structures 559 can be replaced by an anchor structure which
is formed only after the IFIOL 510 is in the eye, for
example, as described elsewhere herein. In addition, the
number of fixation members 518 is not critical to the
present invention. However, it is preferred that at least
three, and more preferably three or four, fixation members
518 be provided.
In contrast to the elongated proximal segments of the
fixation members of the earlier illustrated IFIOLs, the
plate elements 80 are relatively stronger and provide


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
24
enhanced stability. However, the plate elements 80, like
the optic 512, preferably are made of a deformable material
so that the optic and plate elements can be rolled, folded
or otherwise deformed for insertion into an eye through a
small incision.
The relatively strong plate elements 80 provide
substantial benefits. For example, such plate elements 80
facilitate, that is make easier, the placement of IFTOL 510
into the eye. Such placement in the eye requires less time
and/or surgical technique and/or is less traumatic to the
patient and/or is less stressful to the surgeon, relative
to a substantially identical IFIOL in which the plate
elements 80 are replaced by thin filament-like members.
Additionally, after IFIOL 510 is in the eye, the plate
elements 80 are effective in stabilizing the optic 512
against unwanted movement, for example, which can cause
distortion in the patient's vision.
The plate elements 80 can be made of any suitable
material, many examples of which have been disclosed
previously herein. The plate elements 80 can be made
separately from the optic 512 and then bonded or secured to
the optic, or the plate elements and the optic can be made
together as a single piece.
In a preferred embodiment of the invention, the
iridectomy results in through-iris holes that match the
distal segments of the IFIOL to be implanted in the eye.
Further, the IFIOL preferably is designed to prevent
dislodgement of the fixation members from the iris, and not
to interfere with the natural crystalline lens, zonules, or
any other part of the eye. If desired or necessary, the
present IFIOL may be removed from the eye and replaced with
another IFIOL, a PACL, an AIOL, a PIOL, or another eye
implant device.
In embodiments of the invention, at least the terminal
ends of the fixation members may be made of non-transparent


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
material, such as PMMA with a dye, to facilitate observing
the fixation member placement through the iris hole 60
under proper illumination. In a preferred embodiment of
the invention, the remainder of the fixation members are
5 made from visually transparent material to minimize
cosmetic issues.
Enlargement of one or more of the iris holes 60, for
example, after the IFIOL is implanted, may be performed to
increase fluid flow between the anterior and posterior
10 chambers 14 and 30 of the eye 16. In other embodiments of
the invention, the formed or preformed anchor structures
are adapted to permit fluid flow through the iris holes 60.
Embodiments of the invention include IFIOLs that are
implanted to address different refraction deficiencies,
15 such as hyperopia, astigmatism, myopia, and presbyopia.
In preferred embodiments of the invention, the
fixation members and anchor structures, both preformed and
formed in the eye, are adapted to avoid damaging the iris
tissue during insertion, fixation, and removal of the IFIOL
20 from the eye.
While the description above refers to particular
embodiments of the present invention, it will be understood
that many modifications may be made without departing from
the spirit thereof. For example, while Fig. 3 shows the
25 IFIOL 110 implanted in the eye 16 with a natural lens 34,
other embodiments of the invention may have an IFIOL
implanted in an eye without a natural lens, or with a
replacement lens. Another example is a fixation member
having a distal end segment comprising both hydrogel
material and elastic memory material. Further, aspects of
the invention may have combinations of the above described
embodiments although these combinations may not be
explicitly described.
While this invention has been described with respect
to various specific examples and embodiments, it is to be


CA 02397139 2002-07-12
WO 01/50984 PCT/US01/00993
26
understood that the invention is not limited thereto and
that it can be variously practiced within the scope of the
following claims.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2009-10-13
(86) PCT Filing Date 2001-01-10
(87) PCT Publication Date 2001-07-19
(85) National Entry 2002-07-12
Examination Requested 2005-12-23
(45) Issued 2009-10-13
Expired 2021-01-11

Abandonment History

Abandonment Date Reason Reinstatement Date
2003-01-10 FAILURE TO PAY APPLICATION MAINTENANCE FEE 2003-01-22

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2002-07-12
Application Fee $300.00 2002-07-12
Reinstatement: Failure to Pay Application Maintenance Fees $200.00 2003-01-22
Maintenance Fee - Application - New Act 2 2003-01-10 $100.00 2003-01-22
Maintenance Fee - Application - New Act 3 2004-01-12 $100.00 2003-12-18
Maintenance Fee - Application - New Act 4 2005-01-10 $100.00 2004-12-17
Maintenance Fee - Application - New Act 5 2006-01-10 $200.00 2005-12-20
Request for Examination $800.00 2005-12-23
Maintenance Fee - Application - New Act 6 2007-01-10 $200.00 2006-12-20
Maintenance Fee - Application - New Act 7 2008-01-10 $200.00 2007-12-19
Maintenance Fee - Application - New Act 8 2009-01-12 $200.00 2008-12-18
Final Fee $300.00 2009-07-30
Registration of a document - section 124 $100.00 2009-08-04
Maintenance Fee - Patent - New Act 9 2010-01-11 $200.00 2009-12-18
Maintenance Fee - Patent - New Act 10 2011-01-10 $250.00 2010-12-17
Maintenance Fee - Patent - New Act 11 2012-01-10 $250.00 2011-12-16
Maintenance Fee - Patent - New Act 12 2013-01-10 $250.00 2012-12-20
Maintenance Fee - Patent - New Act 13 2014-01-10 $250.00 2013-12-19
Maintenance Fee - Patent - New Act 14 2015-01-12 $250.00 2014-12-22
Maintenance Fee - Patent - New Act 15 2016-01-11 $450.00 2015-12-17
Maintenance Fee - Patent - New Act 16 2017-01-10 $450.00 2016-12-19
Maintenance Fee - Patent - New Act 17 2018-01-10 $450.00 2017-12-20
Registration of a document - section 124 $100.00 2018-09-06
Maintenance Fee - Patent - New Act 18 2019-01-10 $450.00 2018-12-19
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
JOHNSON & JOHNSON SURGICAL VISION, INC.
Past Owners on Record
ABBOTT MEDICAL OPTICS INC.
ADVANCED MEDICAL OPTICS, INC.
LAGUETTE, STEPHEN W.
WEINSCHENK, JOSEPH I., III
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 2002-07-12 1 14
Cover Page 2003-01-24 1 46
Claims 2002-07-12 6 213
Abstract 2002-07-12 1 65
Drawings 2002-07-12 5 124
Description 2007-12-21 26 1,274
Claims 2007-12-21 8 229
Cover Page 2009-09-16 2 47
Representative Drawing 2009-09-16 1 12
Description 2008-10-14 26 1,265
Claims 2008-10-14 8 197
Description 2002-07-12 26 1,279
Claims 2002-07-13 8 309
Claims 2002-07-14 8 264
PCT 2002-07-12 4 172
Assignment 2002-07-12 3 91
Assignment 2002-08-13 3 121
PCT 2002-11-21 1 22
Prosecution-Amendment 2002-07-13 9 272
PCT 2002-07-13 9 337
PCT 2001-01-11 1 66
Fees 2003-01-22 1 41
Assignment 2003-02-19 16 620
PCT 2002-07-13 9 383
Prosecution-Amendment 2002-07-13 9 320
Assignment 2003-05-27 1 22
Correspondence 2003-05-05 1 14
Correspondence 2003-08-14 1 14
Assignment 2003-08-14 3 90
Prosecution-Amendment 2007-12-21 14 466
Assignment 2009-08-04 28 1,691
Prosecution-Amendment 2005-12-23 1 38
Prosecution-Amendment 2006-03-13 1 28
Prosecution-Amendment 2007-06-21 2 62
Prosecution-Amendment 2008-04-14 2 47
Prosecution-Amendment 2008-10-14 8 222
Correspondence 2009-07-30 2 49